ArticleClinical case reports2026
SMARCB1 (INI1)-Deficient Undifferentiated Rectal Carcinoma Mimicking Sarcoma: A Case Report and Literature Review.
Article in Clinical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Undifferentiated carcinomas with rhabdoid morphology and loss of SMARCB1 (INI1) are rare, highly aggressive neoplasms. In the colorectum, they account for < 1% of cases and carry a poor prognosis. We report a 41-year-old man with congenital hemophilia A who presented with pelvic fullness and altered bowel habits. Imaging revealed a large rectosigmoid mass without distant metastasis. Core needle biopsy suggested a high-grade sarcomatoid malignancy. Following multidisciplinary planning and perioperative factor VIII replacement, owing to progressive symptoms and concern for impending obstruction, the patient underwent low anterior resection. Histopathology showed rhabdoid morphology with complete loss of nuclear INI1 expression, confirming SMARCB1-deficient undifferentiated colorectal carcinoma. The tumor was staged as pT4aN0, with vascular invasion. The patient received adjuvant chemoradiation and remained alive and disease-free at the time of publication. This case highlights an important diagnostic pitfall, as SMARCB1-deficient colorectal carcinoma may closely mimic sarcoma on limited biopsy specimens. Recognition of rhabdoid morphology and incorporation of INI1 immunohistochemistry into the diagnostic workup are essential for establishing the correct diagnosis and guiding multidisciplinary treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.